Volume 26, Number 5—May 2020
Synopsis
Epidemiology of Tick-Borne Relapsing Fever in Endemic Area, Spain
Table 2
Main symptoms, signs, and analytical findings of 98 patients with tick-borne relapsing fever, Spain*
Variable | Value | |
---|---|---|
Symptoms | ||
Fever >38.5°C | 97 (99) | |
Headache | 58 (59) | |
Vomiting | 34 (34.7) | |
Arthralgia | 29 (30) | |
Abdominal pain | 28 (28.6) | |
Myalgia | 28 (28.6) | |
Chills | 23 (23.6) | |
Diarrhea |
6 (6.1) |
|
Signs | ||
Meningeal signs | 7 (7.1) | |
Splenomegaly | 7 (7.1) | |
Hepatomegaly | 6 (6.1) | |
Exanthema | 4 (4.1) | |
Jaundice | 3 (3.1) | |
Petechiae | 2 (2) | |
Conjunctival injection |
2 (2) |
|
Analytical findings | ||
Median platelet count, × 103/mm3 (IQR) | 63.5 (45.7–87.5) | |
Thrombocytopenia, platelets <13 × 104/mm3 | 91 (92.9) | |
Hemoglobin, g/dL (IQR) | 13.1 (11.8–14.2) | |
Anemia | 32 (32.6) | |
Leukocytes, ×103/mm3 (IQR) | 7.9 (6.6–9.8) | |
Leukocytosis, >11,500/mm3 | 10 (10.2) | |
Neutrophils, median (IQR) | 79.9 (74.5–86.4) | |
Neutrophilia, neutrophils >65% | 91 (92.9) | |
Prothrombin activity, median (IQR) | 77 (70–87) | |
Decreased prothrombin activity, <70% | 7 (13.7) | |
Median INR (IQR) | 1.2 (1.1–1.3) | |
INR elevation, >1.51 | 7 (13.7) | |
SGOT, U/L (IQR) | 25 (20–35) | |
SGOT elevation, >37 U/L | 15 (21.7) | |
SGPT, U/L (IQR) | 25 (17–41) | |
SGPT elevation, >40 U/L | 10 (23.3) | |
Total bilirubin, mg/dL (IQR) | 1.1 (0.6–1.9) | |
Elevated bilirubin, >1.2 mg/dL | 37 (37.8) | |
Lactate dehydrogenase, U/L(IQR) | 397.5 (320.7–481.7) | |
Elevated LDH, >460 U/L | 16 (30.8) | |
Creatinine, mg/dL (IQR) | 0.94 (0.79–1.15) | |
Creatinine elevation, >1.2 mg/dL | 15 (15.3) | |
Creatine kinase, U/L (IQR) | 41 (27–75) | |
Elevated creatine kinase, >195 U/L | 3 (14) | |
C-reactive protein, mg/L (IQR) | 254.5 (218.2–335.3) | |
Elevated C-reactive protein, >5 mg/L |
98 (100) |
|
*Values are no. (%) except as indicated. INR, international normalized ratio; IQR, interquartile range; SGOT, serum glutamic-oxaloacetic transaminase; SGPT, serum glutamic-pyruvic transaminase. |